Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
DMEQ73
|
|||
Drug Name |
ADPT01
|
|||
Drug Type |
Antibody
|
|||
Indication | Breast cancer [ICD-11: 2C60-2C65; ICD-10: C50, C79.51] | Phase 1 | [1] | |
Company |
Novartis
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Lymphocyte activation gene 3 protein (LAG3) | Target Info | Inhibitor | [1] |
Programmed cell death protein 1 (PD-1) | Target Info | Inhibitor | [1] | |
KEGG Pathway | Cell adhesion molecules (CAMs) | |||
T cell receptor signaling pathway | ||||
Reactome | PD-1 signaling | |||
WikiPathways | T-Cell Receptor and Co-stimulatory Signaling | |||
Costimulation by the CD28 family |
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of Novartis. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.